Phibro Animal Health (PAHC)
(Delayed Data from NSDQ)
$13.61 USD
+0.47 (3.58%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $13.60 -0.01 (-0.07%) 6:08 PM ET
1-Strong Buy of 5 1
A Value B Growth D Momentum B VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
PAHC 13.61 +0.47(3.58%)
Will PAHC be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for PAHC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PAHC
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
Abbott (ABT) Tops Q1 Earnings and Revenue Estimates
PAHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?
Phibro Stock (PAHC) Rises 7% YTD: Will the Run Continue?
Here's Why Investors Should Buy Phibro (PAHC) Stock Now
Other News for PAHC
Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results
Phibro Animal Health About To Put More Money In Your Pocket (PAHC)
Phibro Animal Health Corporation to Participate in Barclays Global Healthcare Conference
PAHC Makes Bullish Cross Above Critical Moving Average
Phibro Animal Health Corporation to Participate in Bank of America 2024 Animal Health Summit